Sarah Atef Eweda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sarah Atef Eweda has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alaa Mohammed
Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Ain Shams University
1 shared publication Aya S. Khater
Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
1 shared publication- Aya Shawky Khater
Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine Ain Shams University
1 shared publication - Doaa M. El Shehaby
Forensic Medicine and Clinical Toxicology department, Faculty of Medicine, Assiut University, Egypt
1 shared publication Eglal Elawady
Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Ain Shams University
1 shared publicationEglal H. Elawady
Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
1 shared publication
Latest Publications
- 19 May 2025
- Published by Taylor & Francis in Biomarkers
- Vol. 30 (4) , 304-314
Evaluation of the role of human neutrophil elastase, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio as predictive markers for severity of acute respiratory toxicity among patients admitted to Poison Control Center of Ain Shams University Hospitals
There are hundreds of xenobiotics that can damage the respiratory system, necessitating mechanical ventilation. Therefore, acute respiratory toxicity may represent a serious condition that can be complicated by acute respiratory distress syndrome (ARDS). This study aimed to evaluate the role of Human Neutrophil Elastase (HNE) as a predictor of acute respiratory toxicity outcome and to compare it with the neutrophil lymphocyte ratio (N/L ratio) and platelet lymphocyte ratio (P/L ratio). This prospective study was conducted on adult patients with acute respiratory toxicity admitted to Poison Control Center; Ain shams university hospitals from January 2022 till December 2022. Their HNE, N/L ratio, and P/L ratio levels were assessed twice: first upon admission and again 24 hours later. Fifty-five patients were enrolled in the study and were classified into ARDS group and non-ARDS group. HNE levels were significantly higher in ARDS patients at both time points with excellent predictive performance. Although the N/L and P/L ratios were significantly elevated in ARDS patients at 30 hours, their diagnostic performance was inferior to HNE. Combining HNE with the N/L ratio offered minimal additional benefit over HNE alone. HNE Level can serve as predictor of ARDS in acutely intoxicated patients.
- 19 May 2025
- Published by Taylor & Francis in Biomarkers
- Vol. 30 (4) , 304-314
Evaluation of the role of human neutrophil elastase, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio as predictive markers for severity of acute respiratory toxicity among patients admitted to Poison Control Center of Ain Shams University Hospitals
There are hundreds of xenobiotics that can damage the respiratory system, necessitating mechanical ventilation. Therefore, acute respiratory toxicity may represent a serious condition that can be complicated by acute respiratory distress syndrome (ARDS). This study aimed to evaluate the role of Human Neutrophil Elastase (HNE) as a predictor of acute respiratory toxicity outcome and to compare it with the neutrophil lymphocyte ratio (N/L ratio) and platelet lymphocyte ratio (P/L ratio). This prospective study was conducted on adult patients with acute respiratory toxicity admitted to Poison Control Center; Ain shams university hospitals from January 2022 till December 2022. Their HNE, N/L ratio, and P/L ratio levels were assessed twice: first upon admission and again 24 hours later. Fifty-five patients were enrolled in the study and were classified into ARDS group and non-ARDS group. HNE levels were significantly higher in ARDS patients at both time points with excellent predictive performance. Although the N/L and P/L ratios were significantly elevated in ARDS patients at 30 hours, their diagnostic performance was inferior to HNE. Combining HNE with the N/L ratio offered minimal additional benefit over HNE alone. HNE Level can serve as predictor of ARDS in acutely intoxicated patients.
- 17 August 2024
- Published by Taylor & Francis in Biomarkers
- Vol. 29 (6) , 376-383
Assessment of the role of N-terminal pro-B-type natriuretic peptide as a predictive biomarker of mortality in acute aluminum phosphide poisoning
Background In Egypt, aluminum phosphide (ALP) is a known lethal poison due to its cardiotoxicity. This study aimed to evaluate the predictive ability of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for mortality in ALP-poisoned patients. Methods: This prospective study was conducted on patients with ALP poisoning admitted to the Poison Control Center Ain Shams University Hospitals between July and December 2022. Upon admission, all patients were followed up and had their levels of NT-proBNP, troponin I (cTnI), and creatine kinase myocardial band (CK-MB) analyzed. Results: Thirty patients were enrolled in the study and were divided into survivors and non-survivors. The initial NT-proBNP levels were significantly higher among non-survivors in contrast to the initial cTnI and CK-MB levels. The study identified that the best cutoff point of NT-proBNP for predicting mortality was ≥72 pg/ml, with AUC (0.869). Conclusion: it can be concluded that NT-proBNP can serve as an early predictor of mortality in ALP poisoning.
- 17 August 2024
- Published by Taylor & Francis in Biomarkers
- Vol. 29 (6) , 376-383
Assessment of the role of N-terminal pro-B-type natriuretic peptide as a predictive biomarker of mortality in acute aluminum phosphide poisoning
Background In Egypt, aluminum phosphide (ALP) is a known lethal poison due to its cardiotoxicity. This study aimed to evaluate the predictive ability of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for mortality in ALP-poisoned patients. Methods: This prospective study was conducted on patients with ALP poisoning admitted to the Poison Control Center Ain Shams University Hospitals between July and December 2022. Upon admission, all patients were followed up and had their levels of NT-proBNP, troponin I (cTnI), and creatine kinase myocardial band (CK-MB) analyzed. Results: Thirty patients were enrolled in the study and were divided into survivors and non-survivors. The initial NT-proBNP levels were significantly higher among non-survivors in contrast to the initial cTnI and CK-MB levels. The study identified that the best cutoff point of NT-proBNP for predicting mortality was ≥72 pg/ml, with AUC (0.869). Conclusion: it can be concluded that NT-proBNP can serve as an early predictor of mortality in ALP poisoning.
- 1 July 2023
- Published by Egyptian Knowledge Bank in Zagazig Journal of Forensic Medicine and Toxicology
- Vol. 21 (2) , 131-147
The Possible Role of Partial Pressure of Carbon dioxide Level Changes in the Outcome of Acute Carbon Monoxide Poisoning
Background: Acute carbon monoxide (CO) poisoning remains a health concern worldwide and is associated with increased morbidity and mortality. Recognizing critical cases is highly valued to provide early efficient management and improve patient outcomes. Aim: This study aims to measure the partial pressure of carbon dioxide (PaCO2) level in patients with acute CO poisoning and to assess the role of PaCO2 level changes in the outcome of acute CO poisoning . Methods: This prospective study was conducted by collecting demographic, clinical data, blood samples from 35 patients with acute CO poisoning admitted to the Poison Control Center, Ain Shams University. Carboxyhemoglobin (COHb), arterial blood gases and cardiac markers were measured on admission. Results: The studied patients with acute CO poisoning were 20 males (57.1%) and 15 females (42.9%), with an average age of 36.3 ± 13.6 years. Patients had lower than normal levels of PaCO2, pH, and HCO3 and higher than normal levels of troponin I and B-Natriuretic Peptide (BNP). A substantial negative weak to moderate correlation was found between the length of the hospital stay and pH, HCO3 and PaCO2 measurements. On the other hand, BNP had a significant positive moderate correlation with length of hospital stay and a negative correlation with PaCO2. Survivors, displayed significantly higher mean levels of PaCO2, pH and HCO3 than cases who died. Conclusion: The current study suggests that changes in PaCO2 levels play an important role in the outcome of patients with acute CO poisoning, potentially acting as a marker of severity and indicating an increased risk of cardiotoxicity. Lower levels of PaCO2 might be associated with a more severe clinical presentation and poorer prognosis. Clinicians could use PaCO2 as a useful clinical indicator to identify patients at a higher risk of adverse outcomes.
- 1 July 2023
- Published by Egyptian Knowledge Bank in Zagazig Journal of Forensic Medicine and Toxicology
- Vol. 21 (2) , 131-147
The Possible Role of Partial Pressure of Carbon dioxide Level Changes in the Outcome of Acute Carbon Monoxide Poisoning
Background: Acute carbon monoxide (CO) poisoning remains a health concern worldwide and is associated with increased morbidity and mortality. Recognizing critical cases is highly valued to provide early efficient management and improve patient outcomes. Aim: This study aims to measure the partial pressure of carbon dioxide (PaCO2) level in patients with acute CO poisoning and to assess the role of PaCO2 level changes in the outcome of acute CO poisoning . Methods: This prospective study was conducted by collecting demographic, clinical data, blood samples from 35 patients with acute CO poisoning admitted to the Poison Control Center, Ain Shams University. Carboxyhemoglobin (COHb), arterial blood gases and cardiac markers were measured on admission. Results: The studied patients with acute CO poisoning were 20 males (57.1%) and 15 females (42.9%), with an average age of 36.3 ± 13.6 years. Patients had lower than normal levels of PaCO2, pH, and HCO3 and higher than normal levels of troponin I and B-Natriuretic Peptide (BNP). A substantial negative weak to moderate correlation was found between the length of the hospital stay and pH, HCO3 and PaCO2 measurements. On the other hand, BNP had a significant positive moderate correlation with length of hospital stay and a negative correlation with PaCO2. Survivors, displayed significantly higher mean levels of PaCO2, pH and HCO3 than cases who died. Conclusion: The current study suggests that changes in PaCO2 levels play an important role in the outcome of patients with acute CO poisoning, potentially acting as a marker of severity and indicating an increased risk of cardiotoxicity. Lower levels of PaCO2 might be associated with a more severe clinical presentation and poorer prognosis. Clinicians could use PaCO2 as a useful clinical indicator to identify patients at a higher risk of adverse outcomes.
- Open Access
- 20 January 2022
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 16 (1) , 1-12
The emerging therapeutic role of some pharmacological antidotes in management of COVID-19
Background: A novel RNA coronavirus was identified in January 2020 as the cause of a pneumonia epidemic affecting the city of Wuhan; it rapidly spread across China.Aim of the review: The aim is to discuss the potential efficacy of some pharmacologically known pharmacological antidotes (N-acetylcysteine; hyperbaric oxygen; deferoxamine; low-dose naloxone) for the management of COVID-19-associated symptoms and complications.Method: An extensive search was accomplished in Medline, Embase, Scopus, Web of Science, and Central databases until the end of April, 2021. Four independent researchers completed the screening, and finally, the associated studies were involved.Conclusion: The current proof hinders the experts for suggesting the proper pharmacological lines of treatment of COVID-19. Organizations, for example, WHO, should pursue more practical actions and design well-planned clinical trials so that their results may be used in the treatment of future outbreaks.
- 20 January 2022
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 16 (1) , 1-12
Open AccessThe emerging therapeutic role of some pharmacological antidotes in management of COVID-19
Background: A novel RNA coronavirus was identified in January 2020 as the cause of a pneumonia epidemic affecting the city of Wuhan; it rapidly spread across China.Aim of the review: The aim is to discuss the potential efficacy of some pharmacologically known pharmacological antidotes (N-acetylcysteine; hyperbaric oxygen; deferoxamine; low-dose naloxone) for the management of COVID-19-associated symptoms and complications.Method: An extensive search was accomplished in Medline, Embase, Scopus, Web of Science, and Central databases until the end of April, 2021. Four independent researchers completed the screening, and finally, the associated studies were involved.Conclusion: The current proof hinders the experts for suggesting the proper pharmacological lines of treatment of COVID-19. Organizations, for example, WHO, should pursue more practical actions and design well-planned clinical trials so that their results may be used in the treatment of future outbreaks.
- 1 July 2021
- Published by Elsevier in NeuroToxicology
- Vol. 85, 115-120
Neuropsychiatric sequelae of acute carbon monoxide poisoning: The predictive role of neuron specific enolase and glial fibrillary acidic protein
- 1 July 2021
- Published by Elsevier in NeuroToxicology
- Vol. 85, 115-120
Neuropsychiatric sequelae of acute carbon monoxide poisoning: The predictive role of neuron specific enolase and glial fibrillary acidic protein